Hi-C (genomic analysis technique)

CitiusTech helps KeyHIE earn NCQA Data Aggregator Validation Certification

Retrieved on: 
Monday, June 12, 2023
DAV, NCQA, National Committee for Quality Assurance, HEDIS, Head, Associate, Certification, Organization, National Committee, Investment, Hi-C (genomic analysis technique), Data, CCD, Continuity, Quality assurance, Continuity of Care Document, SR, Medical device, Nursing, Geisinger

Ltd., a leading provider of healthcare technology services, solutions, and platforms, announced the inclusion of Keystone Health Information Exchange, Inc. (KeyHIE), a subsidiary of Geisinger, as one of a select few health information exchanges (HIEs) in the nation to have achieved Data Aggregator certification by the National Committee for Quality Assurance (NCQA) under its Data Aggregator Validation (DAV) Program.

Key Points: 
  • Ltd., a leading provider of healthcare technology services, solutions, and platforms, announced the inclusion of Keystone Health Information Exchange, Inc. (KeyHIE), a subsidiary of Geisinger, as one of a select few health information exchanges (HIEs) in the nation to have achieved Data Aggregator certification by the National Committee for Quality Assurance (NCQA) under its Data Aggregator Validation (DAV) Program.
  • The NCQA Data Aggregator Validation confirms KeyHIE's capabilities to support healthcare organizations that rely on clinical data streams to fully participate in value-based care initiatives and quality measures such as HEDIS.
  • KeyHIE's certification by NCQA as a Data Aggregator Validation source improves efficiency of clinical data validation processes.
  • Using NCQA's Data Aggregator Validation program elevates the level of accuracy and user trust which will promote further sharing of clinical data."

eHealth Exchange Achieves HITRUST Risk-Based, 2-Year Certification To Further Mitigate Risk in Third-Party Privacy, Security, and Compliance

Retrieved on: 
Wednesday, May 17, 2023
NIST, Privacy, Certification, HITRUST, Organization, EHealth, Hi-C (genomic analysis technique), Risk, Nursing, Medical device

HITRUST Risk-based, 2-year (r2) Certified status demonstrates that eHealth Exchange’s HUB Platform meets key regulations and industry-defined security requirements and is appropriately managing risk.

Key Points: 
  • HITRUST Risk-based, 2-year (r2) Certified status demonstrates that eHealth Exchange’s HUB Platform meets key regulations and industry-defined security requirements and is appropriately managing risk.
  • This achievement places eHealth Exchange in an exclusive group of organizations worldwide that have earned this certification.
  • “HITRUST and NIST certification means eHealth Exchange’s HUB Platform provides the highest standards for data protection and information and validates that eHealth Exchange maintains important standards for sensitive and critical data.
  • “eHealth Exchange’s HUB Platform HITRUST Risk-based, 2-year Certification is evidence that they are at the forefront of industry best practices for information risk management and compliance.”

Abacus Insights Answers Health Plan Executives’ Urgent Call for Direct Data Access with Breakthrough Usable Data Tool

Retrieved on: 
Monday, March 6, 2023
Technology, Health Insurance, Health, Data Management, Geography, MD, CMS, Insight, Abacus, Pharmacy, RISE, 2023, Hi-C (genomic analysis technique), Risk-adjusted return on capital, Risk, TCO, Electronic health record, HITRUST, Medical device

The new tool, MyMetrics, breaks the logjam in getting usable data and metrics flowing to payers’ critical functions and business needs such as risk adjustment, cost-of-care, clinical data, and CMS interoperability so executives have unhindered access for decision-making and management.

Key Points: 
  • The new tool, MyMetrics, breaks the logjam in getting usable data and metrics flowing to payers’ critical functions and business needs such as risk adjustment, cost-of-care, clinical data, and CMS interoperability so executives have unhindered access for decision-making and management.
  • Meet us at RISE National 2023 to discuss the MyMetrics tool and other ways to ensure usable data to improve risk adjustment performance and compliance.
  • Abacus Insights offers more than 100 metrics specific to functions and broader health plan goals.
  • Abacus Insights’ HITRUST CSF-certified and SOC2-certified Data Transformation Platform and Solutions are scalable, compliant, and secure.

Hawai'i Health Information Exchange Selects 4medica To Improve Data Quality

Retrieved on: 
Tuesday, February 14, 2023
Record, Hi-C (genomic analysis technique), Health, Patient safety, Hospital, Patient, Partnership, Data management, HIE, Nursing

HONOLULU, Feb. 14, 2023 /PRNewswire/ -- 4medica®, a leader in healthcare data quality and matching technology, today announced that Hawai'i Health Information Exchange (HHIE) has selected 4medica to work both with the HIE and with contributing data sources such as hospitals, labs, and health centers to improve data quality. Uniquely under this program, 4medica and HHIE will offer 4medica's technology to each health organization under a shared service program.

Key Points: 
  • HONOLULU, Feb. 14, 2023 /PRNewswire/ -- 4medica®, a leader in healthcare data quality and matching technology, today announced that Hawai'i Health Information Exchange (HHIE) has selected 4medica to work both with the HIE and with contributing data sources such as hospitals, labs, and health centers to improve data quality.
  • 4medica has completed a full health data quality assessment for HHIE and has identified data contributors with significant duplicate records.
  • HHIE engaged 4medica and its cloud-based Health Data Quality Platform to uncover data duplication while also understanding the data challenges to their connected sources.
  • The non-profit organization was designated by the state since 2009 to develop a seamless, effective, and secure statewide health information exchange that ultimately links to the nationwide health information network.

Element to Present Data and Innovation Roadmap at AGBT

Retrieved on: 
Monday, February 6, 2023
Cloud, Sequence, ECP, House, Q&A, Workflow, Biochemistry, SVP, Manhattan Center, Hi-C (genomic analysis technique), Q42, Elevate, Mass meeting, Avidity, Chemistry, SAN, Innovation, Grande Ballroom, Genomics, John J. Carty Award for the Advancement of Science, Overalls, Great hall, Genome, Doctor of Philosophy, Fine chemical, Management, Element, Tavarua, Informatics, Software, Q40

SAN DIEGO, Feb. 6, 2023 /PRNewswire/ -- Element Biosciences, Inc.— the developer of an innovative DNA sequencing platform disrupting genomics — will present details about its new Avidity Cloudbreak™ technology and the company's innovation roadmap at the Advances in Genome Biology and Technology (AGBT) General Meeting Feb. 6-9, 2023, in Hollywood, FL.

Key Points: 
  • Element provides the highest quality sequencing on a benchtop for as low as $200 a genome, or $2 per gigabase.
  • Element will present customer data on exome sequencing reporting the majority of bases on AVITI are >Q42, the first commercial platform consistently delivering data quality in excess of Q40.
  • Join Element for a series of talks at AGBT, including:
    Jon Armstrong, VP of Research & Development, Jumpcode Genomics, will present "Boost your single cell studies with CRISPRclean and AVITI: Sequence less and see more usable data."
  • Matthew Kellinger, PhD, Element VP of Biochemistry and Co-Founder, will present data on Element's technology and future outlook in an AGBT Bronze Workshop talk, "Cloudbreak and Beyond: A Roadmap for Innovation" at 2:40 p.m. in the Grand Ballroom.